Italian Life Sciences Database

News in the Life Sciences Industry
Results 81 - 100 out of 147 displayed.
« 1 2 3 4 5 6 7 8 »

European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease

- First CE-IVD-marked blood test that predicts likely progression to Alzheimer's disease up to six years in advance of definitive symptoms;- Received Breakthrough Device designation from U.S. FDA;- Investment supported by European Guarantee Fund's Venture Debt Loan Programme Read more ››

By: PR Newswire Association LLC. - 07 Mar 2022

Related companies: Diadem srl.

Novo Nordisk – major shareholder announcement

By: GlobenewsWire - 04 Mar 2022

Immucor Announces New Innovations in Transplant Diagnostics

By: GlobenewsWire - 04 Mar 2022

Related companies: Immucor Italia SpA | Immucor, Inc. | Immucor Gamma Benelux BvBA | Immucor, S.L.

Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet

By: GlobenewsWire - 03 Mar 2022

Interim Results for the six months ended 31 December 2021

By: GlobenewsWire - 03 Mar 2022

Related companies: Allergy Therapeutics Italy | Allergy Therapeutics plc | Allergy Therapeutics Ibérica, SL

Highlights to be presented at Novo Nordisk’s Capital Markets Day 2022

By: GlobenewsWire - 03 Mar 2022

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

By: GlobenewsWire - 02 Mar 2022

BRACCO IMAGING LAUNCHES NEW SUBSIDIARY, BLUE EARTH THERAPEUTICS, TO ADVANCE DEVELOPMENT OF NEXT GENERATION THERAPEUTIC RADIOPHARMACEUTICAL TECHNOLOGY

"As leaders in health care, we are strongly committed to the field of precision medicine. The creation of Blue Earth Therapeutics marks an exciting new direction for us in addressing unmet needs in patient health," says Fulvio Renoldi Bracco.;Blue Earth Therapeutics is building a pipeline of precision... Read more ››

By: PR Newswire Association LLC. - 01 Mar 2022

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance

By: GlobenewsWire - 28 Feb 2022

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 28 Feb 2022

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

By: GlobenewsWire - 28 Feb 2022

Diadem Receives CE-IVD Certification to Market Its AlzoSure® Predict Prognostic Blood Test for the Early Prediction of Alzheimer's Disease in Europe

--First Approved Blood Test that Can Predict Likely Progression to Alzheimer's Disease Up to Six Years in Advance--;--Clinical Studies Show AlzoSure® Predict Can Identify Whether Individuals with Early Cognitive Impairment Will or Will Not Progress to Alzheimer's Disease with High Accuracy-- Read more ››

By: PR Newswire Association LLC. - 28 Feb 2022

Related companies: Diadem srl.

Genenta to Participate at Upcoming Investor Conferences

By: GlobenewsWire - 24 Feb 2022

Related companies: Genenta Science s.r.l.

NTC Strengthens Digital Customer Engagement with Multichannel Veeva CRM

By: PR Newswire Association LLC. - 16 Feb 2022

Novo Nordisk – major shareholder announcement

By: GlobenewsWire - 14 Feb 2022

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2022
- Digital RESI
- Product & Company Valuation Course
- BIO International Convention 2022

See Events »

Add an Event »

Latest company news

GLOBAL CONFERENCE ON PEDIATRIC PALLIATIVE CARE IN ROME SUPPORTED BY THE FONDAZIONE MARUZZA LEFEBVRE
25 May 2022 (PR Newswire Association LLC.)

Novo Nordisk A/S – Share repurchase programme
23 May 2022 (GlobenewsWire)

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
19 May 2022 (GlobenewsWire)

News in the Life Sciences Industry

European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease

Novo Nordisk – major shareholder announcement

Immucor Announces New Innovations in Transplant Diagnostics

Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet

Interim Results for the six months ended 31 December 2021

Highlights to be presented at Novo Nordisk’s Capital Markets Day 2022

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

BRACCO IMAGING LAUNCHES NEW SUBSIDIARY, BLUE EARTH THERAPEUTICS, TO ADVANCE DEVELOPMENT OF NEXT GENERATION THERAPEUTIC RADIOPHARMACEUTICAL TECHNOLOGY

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance

Novo Nordisk A/S – Share repurchase programme

Election of employee representatives to the Board of Directors of Novo Nordisk A/S

Diadem Receives CE-IVD Certification to Market Its AlzoSure® Predict Prognostic Blood Test for the Early Prediction of Alzheimer's Disease in Europe

Genenta to Participate at Upcoming Investor Conferences

Annual General Meeting in ALK-Abelló A/S on 16 March 2022

Notice for the Annual General Meeting of Novo Nordisk A/S

Novo Nordisk – major shareholder announcement

Novo Nordisk A/S: Share repurchase programme

Regeneron and Sanofi Provide Update on Ongoing Dupixent® (dupilumab) Chronic Spontaneous Urticaria Phase 3 Program

NTC Strengthens Digital Customer Engagement with Multichannel Veeva CRM

Novo Nordisk – major shareholder announcement

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news